SouthState’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
SouthState's CYTK Position: Q3 2026 in Review
SouthState held its Cytokinetics (CYTK) position steady in Q3 2026 at 15 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #1142.
SouthState first reported a position in CYTK in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.28K in Q2 2026. 348 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- SouthState held 15 shares of Cytokinetics worth $989 as of Q3 2026.
- SouthState left its Cytokinetics share count unchanged in Q3 2026.
- Cytokinetics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1142 holding.
- SouthState first reported a position in Cytokinetics in Q1 2025 and has held it in 7 quarters since.
- SouthState's Cytokinetics position peaked at $1.28K in Q2 2026.
- 348 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.